Bioactive compounds and their neuroprotective effects in diabetic complications

Nutrients

Volumn 8, Issue 8, 2016, Pages

  Oh, Yoon Sin ^a,b  

^a Gachon University   (South Korea)

^b Gachon University Gil Hospital   (South Korea)

Author keywords

Diabetes; Flavonoids; Neuroprotection; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BAICALEIN; CHRYSIN; DIOSMIN; EPIGALLOCATECHIN GALLATE; FLAVANONE; FLAVONOID; HESPERIDIN; ISOFLAVONOID; KAEMPFEROL; LUTEOLIN; MYRICETIN; NARINGENIN; PROANTHOCYANIDIN; PUERARIN; QUERCETIN; RETINOIC ACID; RUTOSIDE; SILIBININ; VITAMIN D; NEUROPROTECTIVE AGENT; VITAMIN;

BRAIN BLOOD FLOW; DIABETES MELLITUS; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; NERVE CONDUCTION; NERVE DEGENERATION; NEUROPROTECTION; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; BIOLOGICAL MODEL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENT; METABOLISM;

ANIMALS; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; FLAVONOIDS; HUMANS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; VITAMINS;

EID: 85015586633     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8080472     Document Type: Review

References (148)

1. Atkinson, M.A.; Eisenbarth, G.S. Type 1 diabetes: New perspectives on disease pathogenesis and treatment. Lancet 2001, 358, 221-229. [CrossRef]
2. Lin, Y.; Sun, Z. Current views on type 2 diabetes. J. Endocrinol. 2010, 204, 1-11. [CrossRef] [PubMed]
3. Russell, N.D.; Cooper, M.E. 50 years forward: Mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia 2015, 58, 1708-1714. [CrossRef] [PubMed]
4. Dobretsov, M.; Romanovsky, D.; Stimers, J.R. Early diabetic neuropathy: Triggers and mechanisms. World J. Gastroenterol. WJG 2007, 13, 175-191. [CrossRef] [PubMed]
5. Callaghan, B.C.; Cheng, H.T.; Stables, C.L.; Smith, A.L.; Feldman, E.L. Diabetic neuropathy: Clinical manifestations and current treatments. Lancet. Neurol. 2012, 11, 521-534. [CrossRef]
6. Tesfaye, S.; Selvarajah, D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/Metab. Res. Rev. 2012, 28, 8-14. [CrossRef] [PubMed]
7. Shaikh, A.S.; Somani, R.S. Animal models and biomarkers of neuropathy in diabetic rodents. Indian J. Pharmacol. 2010, 42, 129-134. [PubMed]
8. Ziegler, D.; Sohr, C.G.; Nourooz-Zadeh, J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004, 27, 2178-2183. [CrossRef] [PubMed]
9. Sheetz, M.J.; King, G.L. Molecular understanding of hyperglycemia1s adverse effects for diabetic complications. J. Am. Med. Assoc. 2002, 288, 2579-2588. [CrossRef]
10. Vincent, A.M.; Russell, J.W.; Low, P.; Feldman, E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 2004, 25, 612-628. [CrossRef] [PubMed]
11. Schmidt, A.M.; Hofmann, M.; Taguchi, A.; Yan, S.D.; Stern, D.M. Rage: A multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Semin. Thromb. Hemost. 2000, 26, 485-493. [CrossRef] [PubMed]
12. Yue, D.K.; Hanwell, M.A.; Satchell, P.M.; Turtle, J.R. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes 1982, 31, 789-794. [CrossRef] [PubMed]
13. Cameron, N.E.; Leonard, M.B.; Ross, I.S.; Whiting, P.H. The effects of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat. Diabetologia 1986, 29, 168-174. [CrossRef] [PubMed]
14. Goto, Y.; Hotta, N.; Shigeta, Y.; Sakamoto, N.; Kikkawa, R. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study. Biome. Pharmacother. 1995, 49, 269-277. [CrossRef]
15. Padilla, A.; Descorbeth, M.; Almeyda, A.L.; Payne, K.; de Leon, M. Hyperglycemia magnifies schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res. 2011, 1370, 64-79. [CrossRef] [PubMed]
16. Vincent, A.M.; Hayes, J.M.; McLean, L.L.; Vivekanandan-Giri, A.; Pennathur, S.; Feldman, E.L. Dyslipidemia-induced neuropathy in mice: The role of oxLDL/LOX-1. Diabetes 2009, 58, 2376-2385. [CrossRef] [PubMed]
17. Vincent, A.M.; Perrone, L.; Sullivan, K.A.; Backus, C.; Sastry, A.M.; Lastoskie, C.; Feldman, E.L. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007, 148, 548-558. [CrossRef] [PubMed]
18. Lam, K.S.; Cheng, I.K.; Janus, E.D.; Pang, R.W. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995, 38, 604-609. [CrossRef] [PubMed]
19. Corrao, G.; Zambon, A.; Bertu, L.; Botteri, E.; Leoni, O.; Contiero, P. Lipid lowering drugs prescription and the risk of peripheral neuropathy: An exploratory case-control study using automated databases. J. Epidemiol. Community Health 2004, 58, 1047-1051. [CrossRef] [PubMed]
20. Toth, C.; Brussee, V.; Martinez, J.A.; McDonald, D.; Cunningham, F.A.; Zochodne, D.W. Rescue and regeneration of injured peripheral nerve axons by intrathecal insulin. Neuroscience 2006, 139, 429-449. [CrossRef] [PubMed]
21. Sima, A.A.; Zhang, W.; Grunberger, G. Type 1 diabetic neuropathy and c-peptide. Exp. Diabesity Res. 2004, 5, 65-77. [CrossRef] [PubMed]
22. Pittenger, G.; Vinik, A. Nerve growth factor and diabetic neuropathy. Exp. Diabesity Res 2003, 4, 271-285. [CrossRef] [PubMed]
23. Campbell, C.M.; Kipnes, M.S.; Stouch, B.C.; Brady, K.L.; Kelly, M.; Schmidt, W.K.; Petersen, K.L.; Rowbotham, M.C.; Campbell, J.N. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012, 153, 1815-1823. [CrossRef] [PubMed]
24. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96, 67-202. [CrossRef]
25. Testa, R.; Bonfigli, A.R.; Genovese, S.; de Nigris, V.; Ceriello, A. The possible role of flavonoids in the prevention of diabetic complications. Nutrients 2016, 8, 310. [CrossRef] [PubMed]
26. Lebeau, A.; Esclaire, F.; Rostene, W.; Pelaprat, D. Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity. Neuroreport 2001, 12, 2199-2202. [CrossRef] [PubMed]
27. Gao, Z.; Huang, K.; Xu, H. Protective effects of flavonoids in the roots of scutellaria baicalensis georgi against hydrogen peroxide-induced oxidative stress in Hs-SY5Y cells. Pharmacol. Res. 2001, 43, 173-178. [CrossRef] [PubMed]
28. Li, F.Q.; Wang, T.; Pei, Z.; Liu, B.; Hong, J.S. Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. J. Neural Transm. 2005, 112, 331-347. [CrossRef] [PubMed]
29. Stavniichuk, R.; Drel, V.R.; Shevalye, H.; Maksimchyk, Y.; Kuchmerovska, T.M.; Nadler, J.L.; Obrosova, I.G. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp. Neurol. 2011, 230, 106-113. [CrossRef] [PubMed]
30. Izuta, H.; Shimazawa, M.; Tazawa, S.; Araki, Y.; Mishima, S.; Hara, H. Protective effects of Chinese propolis and its component, chrysin, against neuronal cell death via inhibition of mitochondrial apoptosis pathway in SH-SY5Y cells. J. Agric. Food Chem. 2008, 56, 8944-8953. [CrossRef] [PubMed]
31. Lapidot, T.; Walker, M.D.; Kanner, J. Antioxidant and prooxidant effects of phenolics on pancreatic beta-cells in vitro. J. Agric. Food Chem. 2002, 50, 7220-7225. [CrossRef] [PubMed]
32. Ha, S.K.; Moon, E.; Kim, S.Y. Chrysin suppresses LPS-stimulated proinflammatory responses by blocking NF-kappaB and JNK activations in microglia cells. Neurosci. Lett. 2010, 485, 143-147. [CrossRef] [PubMed]
33. Gresa-Arribas, N.; Serratosa, J.; Saura, J.; Sola, C. Inhibition of CCAAT/enhancer binding protein delta expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J. Neurochem. 2010, 115, 526-536. [CrossRef] [PubMed]
34. Li, R.; Zang, A.; Zhang, L.; Zhang, H.; Zhao, L.; Qi, Z.; Wang, H. Chrysin ameliorates diabetes-associated cognitive deficits in wistar rats. Neurol. Sci. 2014, 35, 1527-1532. [CrossRef] [PubMed]
35. Dholakiya, S.L.; Benzeroual, K.E. Protective effect of diosmin on LPS-induced apoptosis in PC12 cells and inhibition of TNF-alpha expression. Toxicol. Vitro 2011, 25, 1039-1044. [CrossRef] [PubMed]
36. Jain, D.; Bansal, M.K.; Dalvi, R.; Upganlawar, A.; Somani, R. Protective effect of diosmin against diabetic neuropathy in experimental rats. J. Integr. Med. 2014, 12, 35-41. [CrossRef]
37. Srinivasan, S.; Pari, L. Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem. Biol. Interact. 2012, 195, 43-51. [CrossRef] [PubMed]
38. Choi, Y.T.; Jung, C.H.; Lee, S.R.; Bae, J.H.; Baek, W.K.; Suh, M.H.; Park, J.; Park, C.W.; Suh, S.I. The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 2001, 70, 603-614. [CrossRef]
39. Baluchnejadmojarad, T.; Roghani, M. Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: Involvement of oxidative stress. Iranian J. Pharm. Res. 2012, 11, 1243-1253.
40. Raposo, D.; Morgado, C.; Pereira-Terra, P.; Tavares, I. Nociceptive spinal cord neurons of laminae I-III exhibit oxidative stress damage during diabetic neuropathy which is prevented by early antioxidant treatment with epigallocatechin-gallate (EGCG). Brain Res. Bull. 2015, 110, 68-75. [CrossRef] [PubMed]
41. Wang, D.M.; Li, S.Q.; Zhu, X.Y.; Wang, Y.; Wu, W.L.; Zhang, X.J. Protective effects of hesperidin against amyloid-beta (Abeta) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochem. Res. 2013, 38, 1034-1044. [CrossRef] [PubMed]
42. Nones, J.; TC, E.S.; Gomes, F.C. Hesperidin, a flavone glycoside, as mediator of neuronal survival. Neurochem. Res. 2011, 36, 1776-1784. [CrossRef] [PubMed]
43. Visnagri, A.; Kandhare, A.D.; Chakravarty, S.; Ghosh, P.; Bodhankar, S.L. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm. Biol. 2014, 52, 814-828. [CrossRef] [PubMed]
44. Javed, H.; Vaibhav, K.; Ahmed, M.E.; Khan, A.; Tabassum, R.; Islam, F.; Safhi, M.M. Effect of hesperidin on neurobehavioral, neuroinflammation, oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice. J. Neurol. Sci. 2015, 348, 51-59. [CrossRef] [PubMed]
45. El-Marasy, S.A.; Abdallah, H.M.; El-Shenawy, S.M.; El-Khatib, A.S.; El-Shabrawy, O.A.; Kenawy, S.A. Anti-depressant effect of hesperidin in diabetic rats. Can. J. Physiol. Pharm. 2014, 92, 945-952. [CrossRef] [PubMed]
46. Wang, C.N.; Chi, C.W.; Lin, Y.L.; Chen, C.F.; Shiao, Y.J. The neuroprotective effects of phytoestrogens on amyloid beta protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001, 276, 5287-5295. [CrossRef] [PubMed]
47. Al-Numair, K.S.; Chandramohan, G.; Veeramani, C.; Alsaif, M.A. Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. Redox Rep. Commun. Free Radic. Res. 2015, 20, 198-209. [CrossRef] [PubMed]
48. Cheng, H.Y.; Hsieh, M.T.; Tsai, F.S.; Wu, C.R.; Chiu, C.S.; Lee, M.M.; Xu, H.X.; Zhao, Z.Z.; Peng, W.H. Neuroprotective effect of luteolin on amyloid beta protein(25-35)-induced toxicity in cultured rat cortical neurons. Phytother. Res. 2010, 24 (Suppl. 1), S102-S108. [CrossRef] [PubMed]
49. Lin, C.W.; Wu, M.J.; Liu, I.Y.; Su, J.D.; Yen, J.H. Neurotrophic and cytoprotective action of luteolin in PC12 cells through ERK-dependent induction of NRF2-driven Ho-1 expression. J. Agric. Food Chem. 2010, 58, 4477-4486. [CrossRef] [PubMed]
50. Liu, Y.; Tian, X.; Gou, L.; Sun, L.; Ling, X.; Yin, X. Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res. Bull. 2013, 94, 23-29. [CrossRef] [PubMed]
51. Li, M.; Li, Q.; Zhao, Q.; Zhang, J.; Lin, J. Luteolin improves the impaired nerve functions in diabetic neuropathy: Behavioral and biochemical evidences. Int. J. Exp. Pathol. 2015, 8, 10112-10120.
52. Shimmyo, Y.; Kihara, T.; Akaike, A.; Niidome, T.; Sugimoto, H. Three distinct neuroprotective functions of myricetin against glutamate-induced neuronal cell death: Involvement of direct inhibition of caspase-3. J. Neurosci. Res. 2008, 86, 1836-1845. [CrossRef] [PubMed]
53. Vafeiadou, K.; Vauzour, D.; Lee, H.Y.; Rodriguez-Mateos, A.; Williams, R.J.; Spencer, J.P. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys. 2009, 484, 100-109. [CrossRef] [PubMed]
54. Wu, L.H.; Lin, C.; Lin, H.Y.; Liu, Y.S.; Wu, C.Y.; Tsai, C.F.; Chang, P.C.; Yeh, W.L.; Lu, D.Y. Naringenin suppresses neuroinflammatory responses through inducing suppressor of cytokine signaling 3 expression. Mol. Neurobiol. 2016, 53, 1080-1091. [CrossRef] [PubMed]
55. Hasanein, P.; Fazeli, F. Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male wistar rats. J. Physiol. Biochem. 2014, 70, 997-1006. [CrossRef] [PubMed]
56. Al-Rejaie, S.S.; Aleisa, A.M.; Abuohashish, H.M.; Parmar, M.Y.; Ola, M.S.; Al-Hosaini, A.A.; Ahmed, M.M. Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy. Neurol. Res. 2015, 37, 924-933. [CrossRef] [PubMed]
57. Roychowdhury, S.; Wolf, G.; Keilhoff, G.; Bagchi, D.; Horn, T. Protection of primary glial cells by grape seed proanthocyanidin extract against nitrosative/oxidative stress. Nitric Oxide 2001, 5, 137-149. [CrossRef] [PubMed]
58. Bagchi, D.; Garg, A.; Krohn, R.L.; Bagchi, M.; Bagchi, D.J.; Balmoori, J.; Stohs, S.J. Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen. Pharmacol. 1998, 30, 771-776. [CrossRef]
59. Cui, X.P.; Li, B.Y.; Gao, H.Q.; Wei, N.; Wang, W.L.; Lu, M. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J. Nutr. Sci. Vitaminol. 2008, 54, 321-328. [CrossRef] [PubMed]
60. Ding, Y.; Dai, X.; Zhang, Z.; Jiang, Y.; Ma, X.; Cai, X.; Li, Y. Proanthocyanidins protect against early diabetic peripheral neuropathy by modulating endoplasmic reticulum stress. J. Nutr. Biochem. 2014, 25, 765-772. [CrossRef] [PubMed]
61. He, Q.; Yang, S.Y.; Wang, W.; Wu, Z.J.; Ma, H.L.; Lu, Y. Proanthocyanidins affects the neurotoxicity of Abeta25-35 on C57/bl6 mice. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 679-684. [PubMed]
62. Jiang, B.; Liu, J.H.; Bao, Y.M.; An, L.J. Hydrogen peroxide-induced apoptosis in pc12 cells and the protective effect of puerarin. Cell Biol. Int. 2003, 27, 1025-1031. [CrossRef] [PubMed]
63. Cheng, Y.; Leng, W.; Zhang, J. Protective effect of puerarin against oxidative stress injury of neural cells and related mechanisms. Med. Sci. Monit. 2016, 22, 1244-1249. [CrossRef] [PubMed]
64. Xing, G.; Dong, M.; Li, X.; Zou, Y.; Fan, L.; Wang, X.; Cai, D.; Li, C.; Zhou, L.; Liu, J. et al. Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Res. Bull. 2011, 85, 212-218. [CrossRef] [PubMed]
65. Zou, Y.; Hong, B.; Fan, L.; Zhou, L.; Liu, Y.; Wu, Q.; Zhang, X.; Dong, M. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: Involvement of the GSK-3beta/Nrf2 signaling pathway. Free Radic. Res. 2013, 47, 55-63. [CrossRef] [PubMed]
66. Liu, M.; Liao, K.; Yu, C.; Li, X.; Liu, S.; Yang, S. Puerarin alleviates neuropathic pain by inhibiting neuroinflammation in spinal cord. Mediat. Inflamm. 2014, 2014, 485927. [CrossRef] [PubMed]
67. Xi, J.; Zhang, B.; Luo, F.; Liu, J.; Yang, T. Quercetin protects neuroblastoma SH-SY5Y cells against oxidative stress by inhibiting expression of kruppel-like factor 4. Neurosci. Lett. 2012, 527, 115-120. [CrossRef] [PubMed]
68. Shi, Y.; Liang, X.C.; Zhang, H.; Wu, Q.L.; Qu, L.; Sun, Q. Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through NRF-2/HO-1 activation and NF-kB inhibition. Acta Pharmacol. Sin. 2013, 34, 1140-1148. [CrossRef] [PubMed]
69. Qu, L.; Liang, X.; Gu, B.; Liu, W. Quercetin alleviates high glucose-induced schwann cell damage by autophagy. Neural Regen. Res. 2014, 9, 1195-1203. [CrossRef] [PubMed]
70. Wang, W.; Huang, C.Y.; Tsai, F.J.; Tsai, C.C.; Yao, C.H.; Chen, Y.S. Growth-promoting effects of quercetin on peripheral nerves in rats. Int. J. Artif. Organs 2011, 34, 1095-1105. [CrossRef] [PubMed]
71. Xia, S.F.; Xie, Z.X.; Qiao, Y.; Li, L.R.; Cheng, X.R.; Tang, X.; Shi, Y.H.; Le, G.W. Differential effects of quercetin on hippocampus-dependent learning and memory in mice fed with different diets related with oxidative stress. Physiol. Behav. 2015, 138, 325-331. [CrossRef] [PubMed]
72. Kamalakkannan, N.; Prince, P.S. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic Clin. Pharmacol. Toxicol. 2006, 98, 97-103. [CrossRef] [PubMed]
73. Tian, R.; Yang, W.; Xue, Q.; Gao, L.; Huo, J.; Ren, D.; Chen, X. Rutin ameliorates diabetic neuropathy by lowering plasma glucose and decreasing oxidative stress via nrf2 signaling pathway in rats. Eur. J. Pharmacol. 2016, 771, 84-92. [CrossRef] [PubMed]
74. Yin, F.; Liu, J.; Ji, X.; Wang, Y.; Zidichouski, J.; Zhang, J. Silibinin: A novel inhibitor of abeta aggregation. Neurochem. Int. 2011, 58, 399-403. [CrossRef] [PubMed]
75. Wang, M.; Li, Y.J.; Ding, Y.; Zhang, H.N.; Sun, T.; Zhang, K.; Yang, L.; Guo, Y.Y.; Liu, S.B.; Zhao, M.G. et al. Silibinin prevents autophagic cell death upon oxidative stress in cortical neurons and cerebral ischemia-reperfusion injury. Mol. Neurobiol. 2016, 53, 932-943. [CrossRef] [PubMed]
76. Marrazzo, G.; Bosco, P.; La Delia, F.; Scapagnini, G.; Di Giacomo, C.; Malaguarnera, M.; Galvano, F.; Nicolosi, A.; Li Volti, G. Neuroprotective effect of silibinin in diabetic mice. Neurosc. Lett. 2011, 504, 252-256. [CrossRef] [PubMed]
77. Guleria, R.S.; Pan, J.; Dipette, D.; Singh, U.S. Hyperglycemia inhibits retinoic acid-induced activation of rac1, prevents differentiation of cortical neurons, and causes oxidative stress in a rat model of diabetic pregnancy. Diabetes 2006, 55, 3326-3334. [CrossRef] [PubMed]
78. De Bittencourt Pasquali, M.A.; de Ramos, V.M.; Albanus, R.D.; Kunzler, A.; de Souza, L.H.; Dalmolin, R.J.; Gelain, D.P.; Ribeiro, L.; Carro, L.; Moreira, J.C. Gene expression profile of NF-kappaB, NRF2, glycolytic, and p53 pathways during the SH-SY5Y neuronal differentiation mediated by retinoic acid. Mol. Neurobiol. 2016, 53, 423-435. [CrossRef] [PubMed]
79. Huang, J.; May, J.M. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res. 2006, 1097, 52-58. [CrossRef] [PubMed]
80. May, J.M.; Jayagopal, A.; Qu, Z.C.; Parker, W.H. Ascorbic acid prevents high glucose-induced apoptosis in human brain pericytes. Biochem. Biophys. Res. Commun. 2014, 452, 112-117. [CrossRef] [PubMed]
81. Saporito, M.S.; Brown, E.R.; Hartpence, K.C.; Wilcox, H.M.; Vaught, J.L.; Carswell, S. Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in l929 fibroblasts and in adult rat brain. Brain Res. 1994, 633, 189-196. [CrossRef]
82. Neveu, I.; Naveilhan, P.; Baudet, C.; Brachet, P.; Metsis, M. 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not bdnf mrna in astrocytes. Neuroreport 1994, 6, 124-126. [CrossRef] [PubMed]
83. Naveilhan, P.; Neveu, I.; Wion, D.; Brachet, P. 1,25-dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996, 7, 2171-2175. [CrossRef] [PubMed]
84. Riaz, S.; Malcangio, M.; Miller, M.; Tomlinson, D.R. A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 1999, 42, 1308-1313. [CrossRef] [PubMed]
85. Behl, C. Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-beta estradiol and induces the activity of the transcription factor NF-kappaB. J. Neural. Transm. 2000, 107, 393-407. [CrossRef] [PubMed]
86. Choi, J.; Conrad, C.C.; Dai, R.; Malakowsky, C.A.; Talent, J.M.; Carroll, C.A.; Weintraub, S.T.; Gracy, R.W. Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells. Proteomics 2003, 3, 73-77. [CrossRef] [PubMed]
87. Chang, T.I.; Horal, M.; Jain, S.K.; Wang, F.; Patel, R.; Loeken, M.R. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003, 46, 538-545. [PubMed]
88. Baydas, G.; Nedzvetskii, V.S.; Tuzcu, M.; Yasar, A.; Kirichenko, S.V. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: Effects of vitamin E. Eur. J. Pharmacol. 2003, 462, 67-71. [CrossRef]
89. Huang, Y.; Tsang, S.Y.; Yao, X.; Chen, Z.Y. Biological properties of baicalein in cardiovascular system. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005, 5, 177-184. [CrossRef] [PubMed]
90. Cho, H.; Yun, C.W.; Park, W.K.; Kong, J.Y.; Kim, K.S.; Park, Y.; Lee, S.; Kim, B.K. Modulation of the activity of pro-inflammatory enzymes, COX-2 and inos, by chrysin derivatives. Pharmacol. Res. 2004, 49, 37-43. [CrossRef]
91. Kang, S.S.; Lee, J.Y.; Choi, Y.K.; Kim, G.S.; Han, B.H. Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells. Bioorg. Med. Chem. Lett. 2004, 14, 2261-2264. [CrossRef] [PubMed]
92. Akaishi, T.; Morimoto, T.; Shibao, M.; Watanabe, S.; Sakai-Kato, K.; Utsunomiya-Tate, N.; Abe, K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett. 2008, 444, 280-285. [CrossRef] [PubMed]
93. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of citrus flavonoids: New findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185-6205. [CrossRef] [PubMed]
94. Manuel y Keenoy, B.; Vertommen, J.; de Leeuw, I. The effect of flavonoid treatment on the glycation and antioxidant status in type 1 diabetic patients. Diabetes Nutr. Metab. 1999, 12, 256-263. [PubMed]
95. Kang, K.S.; Wen, Y.; Yamabe, N.; Fukui, M.; Bishop, S.C.; Zhu, B.T. Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: In vitro and in vivo studies. PLoS ONE 2010, 5, e11951. [CrossRef] [PubMed]
96. Liu, R.; Zhang, J.; Liang, M.; Zhang, W.; Yan, S.; Lin, M. Simultaneous analysis of eight bioactive compounds in danning tablet by HPLC-ESI-MS and HPLC-UV. J. Pharm. Biomed. Anal. 2007, 43, 1007-1012. [CrossRef] [PubMed]
97. Galati, E.M.; Monforte, M.T.; Kirjavainen, S.; Forestieri, A.M.; Trovato, A.; Tripodo, M.M. Biological effects of hesperidin, a citrus flavonoid. (note I): Antiinflammatory and analgesic activity. Farmaco 1994, 40, 709-712. [PubMed]
98. Monforte, M.T.; Trovato, A.; Kirjavainen, S.; Forestieri, A.M.; Galati, E.M.; Lo Curto, R.B. Biological effects of hesperidin, a citrus flavonoid. (note II): Hypolipidemic activity on experimental hypercholesterolemia in rat. Farmaco 1995, 50, 595-599. [PubMed]
99. Kim, J.K.; Choi, S.J.; Cho, H.Y.; Hwang, H.J.; Kim, Y.J.; Lim, S.T.; Kim, C.J.; Kim, H.K.; Peterson, S.; Shin, D.H. Protective effects of kaempferol (3,41,5,7-tetrahydroxyflavone) against amyloid beta peptide (Abeta)-induced neurotoxicity in ICR mice. Biosci. Biotechnol. Biochem. 2010, 74, 397-401. [CrossRef] [PubMed]
100. Zhang, L.; Gao, H.Y.; Baba, M.; Okada, Y.; Okuyama, T.; Wu, L.J.; Zhan, L.B. Extracts and compounds with anti-diabetic complications and anti-cancer activity from castanea mollissina blume (Chinese chestnut). BMC Complement. Altern. Med. 2014, 14, 422. [CrossRef] [PubMed]
101. Arts, I.C.; Hollman, P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S-325S. [PubMed]
102. Nazari, Q.A.; Kume, T.; Takada-Takatori, Y.; Izumi, Y.; Akaike, A. Protective effect of luteolin on an oxidative-stress model induced by microinjection of sodium nitroprusside in mice. J. Pharm. Sci. 2013, 122, 109-117. [CrossRef]
103. Xu, Y.; Zhang, J.; Liu, J.; Li, S.; Li, C.; Wang, W.; Ma, R.; Liu, Y. Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation. Nat. Prod. Res. 2015, 29, 1078-1082. [CrossRef] [PubMed]
104. Harnly, J.M.; Doherty, R.F.; Beecher, G.R.; Holden, J.M.; Haytowitz, D.B.; Bhagwat, S.; Gebhardt, S. Flavonoid content of U.S. Fruits, vegetables, and nuts. J. Agric. Food Chem. 2006, 54, 9966-9977. [CrossRef] [PubMed]
105. Mira, L.; Fernandez, M.T.; Santos, M.; Rocha, R.; Florencio, M.H.; Jennings, K.R. Interactions of flavonoids with iron and copper ions: A mechanism for their antioxidant activity. Free Radic. Res. 2002, 36, 1199-1208. [CrossRef] [PubMed]
106. Gray, A.M.; Flatt, P.R. Nature’s own pharmacy: The diabetes perspective. Proc. Nutr. Soc. 1997, 56, 507-517. [CrossRef] [PubMed]
107. Kawanishi, K.; Ueda, H.; Moriyasu, M. Aldose reductase inhibitors from the nature. Curr. Med. Chem. 2003, 10, 1353-1374. [CrossRef] [PubMed]
108. Urios, P.; Grigorova-Borsos, A.M.; Sternberg, M. Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur. J. Nutr. 2007, 46, 139-146. [CrossRef] [PubMed]
109. Choi, H.N.; Kang, M.J.; Lee, S.J.; Kim, J.I. Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet. Nutr. Res. Pract. 2014, 8, 544-549. [CrossRef] [PubMed]
110. Liu, I.M.; Liou, S.S.; Lan, T.W.; Hsu, F.L.; Cheng, J.T. Myricetin as the active principle of abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats. Planta Med. 2005, 71, 617-621. [CrossRef] [PubMed]
111. Tjolsen, A.; Berge, O.G.; Hunskaar, S.; Rosland, J.H.; Hole, K. The formalin test: An evaluation of the method. Pain 1992, 51, 5-17. [CrossRef]
112. Freshwater, J.D.; Svensson, C.I.; Malmberg, A.B.; Calcutt, N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 2002, 51, 2249-2255. [CrossRef] [PubMed]
113. O’Connor, A.B.; Dworkin, R.H. Treatment of neuropathic pain: An overview of recent guidelines. Am. J. Med. 2009, 122, S22-S32. [CrossRef] [PubMed]
114. Rahigude, A.; Bhutada, P.; Kaulaskar, S.; Aswar, M.; Otari, K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience 2012, 226, 62-72. [CrossRef] [PubMed]
115. Cos, P.; de Bruyne, T.; Hermans, N.; Apers, S.; Berghe, D.V.; Vlietinck, A.J. Proanthocyanidins in health care: Current and new trends. Curr. Med. Chem. 2004, 11, 1345-1359. [CrossRef] [PubMed]
116. Natella, F.; Belelli, F.; Gentili, V.; Ursini, F.; Scaccini, C. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J. Agric. Food Chem. 2002, 50, 7720-7725. [CrossRef] [PubMed]
117. Prasain, J.K.; Jones, K.; Brissie, N.; Moore, R.; Wyss, J.M.; Barnes, S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 2004, 52, 3708-3712. [CrossRef] [PubMed]
118. Zhang, H.Y.; Liu, Y.H.; Wang, H.Q.; Xu, J.H.; Hu, H.T. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell. Biol. Int. 2008, 32, 1230-1237. [CrossRef] [PubMed]
119. Wu, J.; Zhang, X.; Zhang, B. Efficacy and safety of puerarin injection in treatment of diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials. J. Tradit. Chin. Med. 2014, 34, 401-410. [CrossRef]
120. Nijveldt, R.J.; van Nood, E.; van Hoorn, D.E.; Boelens, P.G.; van Norren, K.; van Leeuwen, P.A. Flavonoids: A review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74, 418-425. [PubMed]
121. Formica, J.V.; Regelson, W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 1995, 33, 1061-1080. [CrossRef]
122. Sasaki, M.; Nakamura, H.; Tsuchiya, S.; Horie, S.; Kashiwayanagi, M.; Saito, T.; Murayama, T. Quercetin-induced PC12 cell death accompanied by caspase-mediated DNA fragmentation. Biol. Pharm. Bull. 2007, 30, 682-686. [CrossRef] [PubMed]
123. Anjaneyulu, M.; Chopra, K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2003, 27, 1001-1005. [CrossRef]
124. Ferreira, P.E.; Lopes, C.R.; Alves, A.M.; Alves, E.P.; Linden, D.R.; Zanoni, J.N.; Buttow, N.C. Diabetic neuropathy: An evaluation of the use of quercetin in the cecum of rats. World J. Gastroenterol. 2013, 19, 6416-6426. [CrossRef] [PubMed]
125. Valensi, P.; Le Devehat, C.; Richard, J.L.; Farez, C.; Khodabandehlou, T.; Rosenbloom, R.A.; LeFante, C. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J. Diabetes Complicat. 2005, 19, 247-253. [CrossRef] [PubMed]
126. Bravo, L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333. [CrossRef] [PubMed]
127. Hosseinzadeh, H.; Nassiri-Asl, M. Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J. Endocrinol. Invest. 2014, 37, 783-788. [CrossRef] [PubMed]
128. Na, J.Y.; Kim, S.; Song, K.; Kwon, J. Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells. Cell. Mol. Neurobiol. 2014, 34, 1071-1079. [CrossRef] [PubMed]
129. Song, K.; Kim, S.; Na, J.Y.; Park, J.H.; Kim, J.K.; Kim, J.H.; Kwon, J. Rutin attenuates ethanol-induced neurotoxicity in hippocampal neuronal cells by increasing aldehyde dehydrogenase 2. Food Chem. Toxicol. 2014, 72, 228-233. [CrossRef] [PubMed]
130. Kobayashi, M.S.; Han, D.; Packer, L. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity. Free Radic. Res. 2000, 32, 115-124. [CrossRef] [PubMed]
131. Tongjaroenbuangam, W.; Ruksee, N.; Chantiratikul, P.; Pakdeenarong, N.; Kongbuntad, W.; Govitrapong, P. Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem. Int. 2011, 59, 677-685. [CrossRef] [PubMed]
132. Alenazi, M.M.; Alkhamees, O.A.; Alroujayee, A.S.; Ahmed, M.M. Protective effects of combined therapy of rutin with silymarin on experimentally induced diabetic neuropathy in rats. Diabetic Med. 2014, 31, 57.
133. Jangra, A.; Kasbe, P.; Pandey, S.N.; Dwivedi, S.; Gurjar, S.S.; Kwatra, M.; Mishra, M.; Venu, A.K.; Sulakhiya, K.; Gogoi, R. et al. Hesperidin and silibinin ameliorate aluminum-induced neurotoxicity: Modulation of antioxidants and inflammatory cytokines level in mice hippocampus. Biol. Trace Elem. Res. 2015, 168, 462-471. [CrossRef] [PubMed]
134. Geed, M.; Garabadu, D.; Ahmad, A.; Krishnamurthy, S. Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats. Pharmacol. Biochem. Behav. 2014, 117, 92-103. [CrossRef] [PubMed]
135. Lee, Y.; Park, H.R.; Chun, H.J.; Lee, J. Silibinin prevents dopaminergic neuronal loss in a mouse model of parkinson’s disease via mitochondrial stabilization. J. Neurosci. Res. 2015, 93, 755-765. [CrossRef] [PubMed]
136. Hernandez-Pedro, N.; Ordonez, G.; Ortiz-Plata, A.; Palencia-Hernandez, G.; Garcia-Ulloa, A.C.; Flores-Estrada, D.; Sotelo, J.; Arrieta, O. All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy. Transl. Res. 2008, 152, 31-37. [CrossRef] [PubMed]
137. Arrieta, O.; Garcia-Navarrete, R.; Zuniga, S.; Ordonez, G.; Ortiz, A.; Palencia, G.; Morales-Espinosa, D.; Hernandez-Pedro, N.; Sotelo, J. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice. Eur. J. Clin. Invest. 2005, 35, 201-207. [CrossRef] [PubMed]
138. Rice, M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000, 23, 209-216. [CrossRef]
139. May, J.M. Vitamin C transport and its role in the central nervous system. Subcell. Biochem. 2012, 56, 85-103. [PubMed]
140. Harrison, F.E.; May, J.M. Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009, 46, 719-730. [CrossRef] [PubMed]
141. Huang, Y.N.; Yang, L.Y.; Wang, J.Y.; Lai, C.C.; Chiu, C.T. L-Ascorbate protects against methamphetamine-induced neurotoxicity of cortical cells via inhibiting oxidative stress, autophagy, and apoptosis. Mol. Neurobiol. 2016. [CrossRef] [PubMed]
142. Ebrahimzadeh-Bideskan, A.R.; Hami, J.; Alipour, F.; Haghir, H.; Fazel, A.R.; Sadeghi, A. Protective effects of ascorbic acid and garlic extract against lead-induced apoptosis in developing rat hippocampus. Metab. Brain Dis. 2016. [CrossRef] [PubMed]
143. Soderstrom, L.H.; Johnson, S.P.; Diaz, V.A.; Mainous, A.G. Association between vitamin D and diabetic neuropathy in a nationally representative sample: Results from 2001 to 2004 nhanes. Diabet. Med. 2012, 29, 50-55. [CrossRef] [PubMed]
144. Lee, P.; Chen, R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch. Int. Med. 2008, 168, 771-772. [CrossRef] [PubMed]
145. Burton, G.W.; Traber, M.G. Vitamin E: Antioxidant activity, biokinetics, and bioavailability. Annu. Rev. Nutr. 1990, 10, 357-382. [CrossRef] [PubMed]
146. Skalska, S.; Kyselova, Z.; Gajdosikova, A.; Karasu, C.; Stefek, M.; Stolc, S. Protective effect of stobadine on ncv in streptozotocin-diabetic rats: Augmentation by vitamin E. Gen. Physiol. Biophys. 2008, 27, 106-114. [PubMed]
147. Van Dam, P.S.; Bravenboer, B.; van Asbeck, B.S.; Marx, J.J.; Gispen, W.H. High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. Eur. J. Pharmacol. 1999, 376, 217-222. [CrossRef]
148. Ogbera, A.O.; Ezeobi, E.; Unachukwu, C.; Oshinaike, O. Treatment of diabetes mellitus-associated neuropathy with vitamin E and eve primrose. Indian J. Endocrinol. Metab. 2014, 18, 846-849. [CrossRef] [PubMed]